[Cys7]-beta-Amyloid (1-40) features an N-terminal substitution that supports redox-sensitive probing of early conformational events. The introduced cysteine offers opportunities for labeling, disulfide chemistry, and structural stabilization studies. Researchers employ the analog to examine nucleation behavior and peptide-lipid interactions. Its well-defined sequence aids investigations in aggregation biophysics.
CAT No: A13264
2. Implications of ligand-receptor binding kinetics on GLP-1R signalling
3. TMEM16F and dynamins control expansive plasma membrane reservoirs
5. Autoinhibition and phosphorylation-induced activation of phospholipase C-γ isozymes
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More